Introduction
In the last few years, the increased efficacy of combined antiretroviral therapy (cART) has resulted in a marked reduction in HIV-related morbidities and mortality, and a considerable improvement in the quality of life of people living with HIV (PLWHIV) [1] [2] [3] . However, this evolution to a chronic condition has been associated with increasing frequencies of non-AIDS-related comorbidities (including psychological morbidities) linked to aging and the burden of disease and treatment [4, 5] .
In the HIV-infected population, depression is known to be negatively associated with HIV/AIDS treatment adherence, therapeutic outcomes and risky behaviours [6] [7] [8] , with a potential impact on medical and social outcomes. Consequently, it is important to measure and understand the burden of depression among PLWHIV.
Recently published studies report particularly high levels of depression among PLWHIV world-wide [4, [9] [10] [11] [12] [13] . However, the estimated prevalence is often the overall prevalence. Yet, the HIV-infected population consists of various groups with very different socioeconomic and behavioural characteristics [14] . A number of reports focus on one specific group, most often men who have sex with men (MSM) or injecting drug users (IDUs) [12] , but limited attention has been paid to the comparison of depression among the various groups of PLWHIV.
Some studies have reported that the prevalence of depression among PLWHIV is 2-3 times higher than in the general population [13, 15] . However, PLWHIV differ markedly from the general population in terms of their sociodemographic and socioeconomic characteristics, which are not usually taken into account in the comparison. Our objectives were [1] to estimate the prevalence of major depressive episode (MDE) among the various groups of PLWHIV, [2] to compare this with the prevalence of MDE in the general population, accounting for the specific socioeconomic profile of PLWHIV, and [3] to identify factors associated with MDE.
Methods

Study population
Data on PLWHIV were obtained from the ANRS-Vespa2 study (VIH: Enquête sur les personnes atteintes), a national cross-sectional representative survey aimed primarily at assessing the various dimensions of the socioeconomic and health-related characteristics of PLWHIV in France in their diversity [16, 17] . The study was conducted between April 2011 and January 2012 among PLWHIV aged ≥ 18 years who had a diagnosis of HIV infection of at least 6 months' duration and who were either French citizens or immigrants who had been living in France for at least 6 months. They were recruited in 73 hospital departments in France randomly selected from among all the hospital settings delivering HIV care. A total of 5617 individuals were randomized. Of these, 378 were not asked to participate and 1767 declined to participate. Thus, a total of 3022 participants answered a standardized questionnaire administered face to face by a trained interviewer. The questionnaire contained detailed questions on sociodemographic characteristics, living conditions, health and health care. The data were weighted to account for the sampling design and nonparticipation. Details of the weighting procedure are provided elsewhere [16, 17] . The survey was approved by the French Advisory Committee on Information Processing in Material Research in the Field of Health and met the ethical requirements of the French National Commission for Computing and Liberties.
Data on the general population were obtained from the 2010 Barom etre Sant e, a French national health survey conducted every 5 years by the French Institute for Health Promotion and Health Education (INPES) [18] . Data were collected by telephone from a national representative sample of 27 653 noninstitutionalized residents aged 15-85 years. The estimated refusal rate was 39%. Questions on depression were administered to a randomly selected subsample of 8782 participants.
Variables of interest
Major depressive episode
In both studies, the occurrence of major depressive episode (MDE) during the preceding 12-month period was assessed using the short form of the depression module of the World Health Organization's Composite International Diagnostic Instrument (CIDI-SF) [19] . This fully structured instrument is used to diagnose mental disorders according to the definitions and criteria in the International Classification of Diseases (ICD-10) and the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). A 12-month MDE is defined as a period of at least 2 weeks with the presence of at least five of the eight core depressive symptoms, and affecting daily activities. MDE was considered to be of severe intensity if the individual reported at least seven of the eight depressive symptoms with significant disruption of daily activities. As hepatitis C treatment provided in 2011 was peginterferon and ribavirin, with a high risk of depression as an adverse effect [20] , participants with chronic hepatitis C who were currently on therapy or who had stopped receiving such therapy < 6 months earlier were excluded from the study. Patients included in the present study were classified as untreated hepatitis C vs. no hepatitis C.
Covariates
Data on sociodemographic and socioeconomic characteristics were collected in both studies, including age (25-34, 35-44, 45-54 or 55-65 years), household composition (single, living in a couple with no children, or living in a couple with at least one child), educational attainment (primary level, less than a high school diploma, a high school diploma, or more than a high school diploma) and occupational status (employed, unemployed, on disability benefits, retired or inactive). Monthly income was categorized in three groups (< €1100, €1100À1800 and > €1800) based on tertiles.
In addition, the available data on PLWHIV included the following social and health indicators: material deprivation [yes (at least four out of nine privations (food, clothes, etc.)) or no], participation in activities proposed by associations helping HIV-infected people during the previous year (yes or no), experience of discrimination during the previous 2 years (yes, on the basis of HIV; yes, on some other basis; or no discrimination), the period of HIV diagnosis (after 2008; between 1997 and 2008; or before 1997), being on cART with a viral load < 50 HIV-1 RNA copies/mL (yes or no), cancer in the previous 5 years (yes or no), chronic hepatitis B (yes or no), untreated hepatitis C [yes or no (no hepatitis C)] and cardiovascular risk documented from medical records [yes (diabetes, hypertension or cardiovascular disease) or no]. For each participant, the proportion of family and friends to whom his/her HIV status had been disclosed was categorized in four groups (none, less than half, more than half, and all).
HIV-infected individuals were divided into seven mutually exclusive categories, which correspond to the major groups of PLWHIV in France and which differ markedly in terms of HIV epidemic dynamics and socioeconomic conditions [14, 21] : injecting drug-using men or women (IDU men/women); men who have sex with men (MSM); sub-Saharan African (SSA) migrant men or women; and non-drug-using, non-SSA heterosexual men or women.
Statistical analyses
The statistical analyses were limited to individuals aged 25-65 years for whom information on depression was available and who did not have a current or recent history of hepatitis C therapy at the time of the interview. Individuals with missing information for the variables used in the models were excluded from the analyses.
The first step consisted of determining MDE prevalence and describing severity overall and by group of PLWHIV.
IDUs were excluded from the remaining analyses because of their very specific susceptibility to depression, regardless of their HIV status [22, 23] .
MDE prevalence was compared between each group of HIV-infected men or women and the general population of the same gender (but not taking into account sexual orientation and origin). Adjusted prevalence rate ratios (aPRRs) were determined using multivariate Poisson regression models with robust variance [24] . Each model was adjusted for age, household composition, educational attainment, occupational status and monthly income.
Finally, the factors associated with MDE were assessed in the HIV-positive population using multivariate Poisson regression models with robust variance. The covariates included in the models were sociodemographic and economic characteristics, comorbidities, social relations, and HIV-related characteristics. Covariates with a P-value < 0.10 in the crude models were included in the multivariate models. To make sure that including all the groups of PLWHIV in the same model did not affect our results, we performed additional analyses stratifying by group which globally resulted in the same associated factors for each group (data not presented here).
All the analyses were performed using STATA 12 (Stata Corporation, College Station, TX, USA) and accounted for the data weighting so that the estimates would be representative of the entire HIV-infected population followed at hospitals in France in 2011 or of the general population in France in 2010.
Results
Demographics of the study population
Of the 2392 PLWHIV included in this study, 40% were MSM, 25% were SSA migrants (men: 8%; women: 17%), 25% were non-SSA heterosexuals (men: 12%; women: 13%) and 10% were IDUs (men: 6%; women: 4%). These groups varied in terms of age (the median age ranging from 39 years among the SSA migrant women to 51 years among the non-SSA heterosexual men) and household composition (the proportion of individuals living as a couple with one or more children ranging from 2.4% among the MSM to 35.1% among SSA migrant men) ( Table 1 ). There were also marked differences in terms of educational attainment (the proportion of individuals with more than a high school diploma ranging from 7.8% among the IDU men to 44% among the MSM), occupational status (the proportion of unemployed individuals ranging from 6.4% among the MSM to 24.9% among the SSA migrant women) and income (the lower quartile of monthly income ranging from €540 among the SSA migrant women to €1300 among the MSM).
Among the 5859 respondents in the general population aged 25-65 years, the proportion of men was 49.2%. The median age was 44 years among the men and 45 years among the women. Of the men and women, respectively, 40.1% and 32.2% were living as a couple with one or more children. One-quarter of respondents had more than a high school diploma, and a minority were unemployed (men: 10.8%; women: 7.5%). The lower quartile of monthly income was €972 among the men and €900 among the women. Twenty per cent of the general population had a chronic disease.
Major depressive episode across the various groups of HIV-infected persons
Overall, 28.1% of the HIV-infected participants had experienced an MDE during the previous 12 months. The prevalence of depression varied considerably across the groups of PLWHIV (Fig. 1) . Among the men, the rate of depression was 32.8% in the IDUs, 31.3% in the MSM, 18.3% in the non-SSA heterosexuals and 10.9% in the SSA migrants. Among the women, it was 55.7% in the IDUs, 29.7% in the non-SSA heterosexuals and 27.0% in the SSA migrants. Severe MDE was noted for 9.3% of the HIV-infected individuals. The rate of severe MDE, too, varied significantly across the groups, from 1.6% in the SSA migrant men to 35.0% in the IDU women. One-third of individuals with MDE had had their first episode prior to HIV diagnosis.
Comparison with the general population
In the general population, 6.0% of men and 9.9% of women had experienced an MDE during the previous 12 months. After adjustment for age, household composition, educational attainment, occupational status and income, the prevalence of MDE remained higher among PLWHIV compared with the general population of the same gender ( Table 2 ). The HIV-infected MSM (aPRR 5.12; 95% CI 3.94-6.64; P = 0.000) and HIV-infected non-SSA heterosexual men (aPRR 3.13; 95% CI 2.21-4.42; P = 0.000) had a significantly higher prevalence of MDE than men in the general population, but the difference between the HIV-infected SSA migrant men and men in the general population was not significant (aPRR 1.55; 95% CI 0.93-2.60; P = 0.094). Among the women, the HIV-infected non-SSA heterosexual women (aPRR 2.61; 95% CI 2.06-3.32; P = 0.000) and HIV-infected SSA migrant women (aPRR 1.94; 95% CI 1.50-2.50; P = 0.000) were significantly more likely to have had an MDE than women in the general population.
Characteristics associated with major depressive episode in the HIV-infected population
In univariate analysis ( In the final multivariate model (Table 3) , MDE prevalence always decreased with age. The prevalence among PRR, prevalence rate ratio (unadjusted); aPRR, prevalence rate ratio adjusted for age, household composition, educational attainment, occupational status and income; CI, confidence interval; MSM, men who have sex with men; SSA, sub-Saharan African. Significance level: ***P < 0.001; ** P < 0.01; *P < 0.05. ; P = 0.000) were associated with a higher prevalence of MDE. The prevalence was also higher among those with untreated hepatitis C (aPRR 1.60; 95% CI 1.16-2.20).
Discussion
Our results indicate that, in France, almost 3 in 10 HIVinfected people had experienced an MDE in the previous 12-month period. The prevalence of MDE varied from 10.9 to 55.7% across the various groups of PLWHIV. Compared with the general population of the same gender, HIV-infected men had a 1.55-to 5.12-fold higher prevalence, and HIV-infected women had a 1.94-to 2.61-fold higher prevalence. In the HIV-infected population, the prevalence of MDE was negatively related to age and appeared to be positively related to unemployment, material deprivation, disclosure, experience of discrimination and having untreated hepatitis C. The use of the CIDI-SF constitutes a major strength of our study. It is a widely validated and widely used diagnostic test for depression in international studies [25] [26] [27] [28] , including HIV studies [29] [30] [31] . The CIDI-SF is convergent with the full-length CIDI [19] . There are many different depression scales, which often makes it difficult to compare data between studies, but the CIDI-SF was used as a tool for measuring depression both in the ANRS-Vespa2 study and in the 2010 Barom etre Sant e survey, with the result that a comparison was possible. Of note, data were collected face to face in HIV-infected people vs. by phone in the general population. However, we did not find any evidence suggesting that the mode of administration leads to different responses to the CIDI-SF questionnaire. Another significant strength is the nationally representative nature of the ANRS-Vespa2 data set, as well as the availability of detailed sociodemographic, economic and HIV-related information. However, it should be noted that the study was limited to HIV-infected persons attending hospitals for HIV care. Presently, in France, HIV care is essentially provided at hospitals, and since 2006, experts have been recommending that all PLWHIV have at least an annual check-up at a hospital [32] . Estimates are therefore likely to apply to the vast majority of PLWHIV being treated in France. Yet, because the ANRS-Vespa2 study was cross-sectional, our findings describe MDE during the previous 12 months. Only the year of the first episode of depression can account for the individual depression history.
The prevalence of MDE among HIV-infected individuals is consistent with recent European studies [33, 34] . The higher prevalence of MDE than in the general population is also consistent with the few reports in which such a comparison has been made. A meta-analysis found a 2-fold higher frequency of MDE in seropositive individuals than in seronegative individuals [13] , although it did not take the specific socioeconomic profile of PLWHIV into account. In the USA, HIV-infected persons were recently found to have a 3-fold higher prevalence of depression than the general population [15] when gender and, in turn, age, race/ethnicity and education were controlled for. However, when controlled for gender and annual household income, the prevalence was 1.5-fold higher, which indicates that the difference in income between the two populations played an important role. In our study, the comparison accounted simultaneously for the characteristics of the PLWHIV, and controlling for monthly PRR, prevalence rate ratio (unadjusted); aPRR, prevalence rate ratio adjusted for socioepidemiological group, age, household composition, educational attainment, occupational status, material deprivation, proportion of family and friends informed of HIV status, participation in AIDS association activities or being an activist, discrimination, cancer, chronic hepatitis B, chronic hepatitis C, period of HIV diagnosis and virological success; cART, combination antiretroviral therapy; CI, confidence interval; MSM, men who have sex with men; SSA, sub-Saharan African.
Significance level: ***P < 0.001; **P < 0.01; *P < 0.05.
income did not reduce the PRR. The difference between the HIV-infected population and the general population is much wider than differences observed within the general population, for instance for the materially deprived vs. the well-off [35] , or the difference between people with cancer and those without cancer [36] . In this study, each socioepidemiological group of PLWHIV was considered separately. IDU men and women had the highest prevalence of MDE of all the groups, as reported in recent reviews [12, 37] . MSM were also a highrisk group for depression in the HIV-infected population in our study, as well as in previous reports [12, 37] . Considering the low proportion of MSM in the general population (0.4% using the definition of male-to-male sex in the last 12 months), the comparison was made with the entire male population. MSM are known to be at high risk for psychological disorders compared with the rest of the population. A meta-analysis revealed a 1.5-fold higher risk of depression and anxiety disorders, and a 2-fold higher risk of suicide attempts [38] . Therefore, our PRR probably reflects differences in HIV serostatus but also differences between MSM and heterosexuals. Conversely, HIVinfected SSA migrant men and women tended to be less depressed than other groups of men and women. However, the rate of depression was higher among the HIV-infected SSA migrants in our study than those reported among HIV-infected populations in sub-Saharan Africa [39, 40] . This is consistent with studies that reported higher rates of depression among migrants than among the population in their country of origin [41] . Compared with the general population of the same gender, the prevalence of depression was higher among SSA migrant women but not significantly so among SSA migrant men. Women could be affected more than men because they are more isolated, less educated and more deprived [42] , as observed in the ANRS-Vespa2 study. Considering the low proportion of SSA migrants in the general population (0.6% in the Barom etre Sant e sample), the population of reference actually consisted mostly of non-SSA heterosexuals. Some studies have reported a slightly higher lifetime prevalence of depression in the entire migrant population than in the general population [41] . Therefore, our PRR probably reflects differences in HIV serostatus but also differences between migrants and nonmigrants. In addition, the crosscultural validity of the French version of the CIDI-SF among migrant subgroups might be questioned.
Our findings indicate a higher prevalence of MDE among seropositive women than seropositive men, which is consistent with recent reviews [9, 10, 12, 43] . Other characteristics, such as age, employment status and level of income, are commonly associated with depression among PLWHIV [9, 10, 12, 15] and such associations were also observed in this study. In the general population of most countries, there is also a high correlation with sex, age, marital status, employment status and level of income [44, 45] . Therefore, sociodemographic and economic characteristics related to depression are similar in the two populations. However, the adjusted prevalence rate of depression is higher among PLWHIV than in the general population, the hypothesis being that HIV disease plays a role in this. For instance, discrimination is known to be frequent and persistent against PLWHIV [46] . Our results indicate a positive association between MDE and experience of discrimination, regardless of the perceived reason. The disclosure of HIV status is another important concern. The more PLWHIV informed their close relatives (family and friends), the higher the prevalence of MDE, suggesting two possible interpretations: disclosure was made to seek support to cope with depression, or disclosure contributed to depression as a consequence of negative attitudes and discrimination. However, data are lacking to enable these possibilities to be disentangled. Indeed, because of the cross-sectional design of our study, disclosure status before the onset of MDE was not known. A recent German study reported no association between PLWHIV's mental health status and disclosure or social support experienced [47] . Finally, the association between having depression and untreated hepatitis C needs to be considered with caution but is a clue that hepatits C is a marker of vulnerability. More generally, there is no possible causal interpretation of the association between MDE and the characteristics of HIV-infected individuals [9] . On the one hand, people with mental disorders, such as MDE, would have an increased risk of exposure to HIV infection. On the other hand, several HIV-related psychosocial or biological factors could lead to the development of depression, such as stigma or a persistent viral presence in the central nervous system.
In conclusion, the results of this study show that, despite the major improvements in HIV care and treatment, the prevalence of depression remains much higher in the HIV-infected population than in the general population. Moreover, depression rates vary across the groups of PLWHIV and are strongly related to socioeconomic status and enduring discrimination. Conflicts of interest: The authors have no conflict of interest to disclose.
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